The Sangre Por Salud Biobank: Facilitating Genetic Research in an Underrepresented Latino Community

Background/Aims: The Sangre Por Salud (Blood for Health; SPS) Biobank was created for the purpose of expanding precision medicine research to include underrepresented Latino patients. It is the result of a unique collaboration between Mayo Clinic and Mountain Park Health Center, a federally qualified community health center in Phoenix, Arizona. This report describes the rationale, development, implementation, and characteristics of the SPS Biobank. Methods: Latino adults (ages 18-85 years) who were active patients within Mountain Park Health Center's internal medicine practice in Phoenix, Ariz., and had no history of diabetes were eligible. Participants provided a personal and family history of chronic disease, completed a sociodemographic, psychosocial, and behavioral questionnaire, underwent a comprehensive cardiometabolic risk assessment (anthropometrics, blood pressure and labs), and provided blood samples for banking. Laboratory results of cardiometabolic testing were returned to the participants and their providers through the electronic health record. Results: During the first 2 years of recruitment into the SPS Biobank, 2,335 patients were approached and 1,432 (61.3%) consented to participate; 1,354 (94.5%) ultimately completed all requisite questionnaires and medical evaluations. The cohort is primarily Spanish-speaking (72.9%), female (73.3%), with a mean age of 41.3 ± 12.5 years. Most participants were born outside of the US (77.9%) and do not have health insurance (77.5%). The prevalence of overweight (35.5%) and obesity (45.0%) was high, as was previously unidentified prediabetes (55.9%), type 2 diabetes (7.4%), prehypertension (46.8%), and hypertension (16.2%). The majority of participants rated their health as good to excellent (72.1%) and, as a whole, described their overall quality of life as high (7.9/10). Conclusion: Collaborative efforts such as the SPS Biobank are critical for ensuring that underrepresented minority populations are included in precision medicine initiatives and biomedical research that seeks to improve human health and reduce the burdens of disease.

[1]  Maíra R. Rodrigues,et al.  Genomic Ancestry, Self-Rated Health and Its Association with Mortality in an Admixed Population: 10 Year Follow-Up of the Bambui-Epigen (Brazil) Cohort Study of Ageing , 2015, PloS one.

[2]  Stuart J. Ritchie,et al.  Molecular genetic contributions to self-rated health , 2015, bioRxiv.

[3]  Jennifer B. McCormick,et al.  Prudentia Populo: Involving the Community in Biobank Governance , 2015, The American journal of bioethics : AJOB.

[4]  V. Chang,et al.  Mortality Attributable to Low Levels of Education in the United States , 2015, PloS one.

[5]  R. Cooper,et al.  Systematic Reviews and Meta- and Pooled Analyses The Contribution of Genomic Research to Explaining Racial Disparities in Cardiovascular Disease: A Systematic Review , 2015 .

[6]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[7]  Mark D Hayward,et al.  Trends and group differences in the association between educational attainment and U.S. adult mortality: implications for understanding education's causal influence. , 2015, Social science & medicine.

[8]  K. Norris,et al.  A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. , 2014, American journal of public health.

[9]  M. Burgess,et al.  From ‘trust us’ to participatory governance: Deliberative publics and science policy , 2014, Public understanding of science.

[10]  Kiley J. Johnson,et al.  The Mayo Clinic Biobank: a building block for individualized medicine. , 2013, Mayo Clinic proceedings.

[11]  R. Kulesher Health Reform’s Impact on Federally Qualified Community Health Centers: The Unintended Consequence of Increased Medicaid Enrollment on the Primary Care Medical Home , 2013, The health care manager.

[12]  Timothy B. Smith,et al.  Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature. , 2013, American journal of public health.

[13]  Leroi S. Hicks,et al.  A systematic review of community-based participatory research to enhance clinical trials in racial and ethnic minority groups. , 2012, Health services research.

[14]  D. Sacks A1C Versus Glucose Testing: A Comparison , 2011, Diabetes Care.

[15]  C. Haiman,et al.  Exploring genetic susceptibility to cancer in diverse populations. , 2010, Current opinion in genetics & development.

[16]  D. Stoff,et al.  Moving toward paradigm-shifting research in health disparities through translational, transformational, and transdisciplinary approaches. , 2010, American journal of public health.

[17]  Susanne B Haga,et al.  Impact of limited population diversity of genome-wide association studies , 2010, Genetics in Medicine.

[18]  W. Vega,et al.  Health disparities in the Latino population. , 2009, Epidemiologic reviews.

[19]  J. Belmont,et al.  The futility of genomic counseling: essential role of electronic health records , 2009, Genome Medicine.

[20]  Jiang He,et al.  Mortality prediction with a single general self-rated health question , 2006, Journal of General Internal Medicine.

[21]  P. Sorlie,et al.  A comparison of the relationships of education and income with mortality: the National Longitudinal Mortality Study. , 1999, Social science & medicine.

[22]  Deborah G Duran Lack of Hispanics’ Involvement in Research – Is It Hispanics or Scientists? , 1999, Public Health Genomics.

[23]  A. Coates,et al.  On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. , 1983, European journal of cancer & clinical oncology.

[24]  J. Passel U.S. Population Projections: 2005-2050 , 2008 .